`
`Inventors: OKSCHE er a].
`
`Confirmation No.: 8650
`
`Applicant: PURDUE PHARMA L.P.
`
`Art Unit: 1628
`
`Application No.: 15/442,231
`
`Examiner: RICCI, Craig D.
`
`Filing Date: February 24, 2017
`
`Atty. Docket: 1861.2700005/J1VIC/1VISB
`
`Title: Buprenorphine-Wafer for Drug Substitution Therapy
`
`First Supplemental Information Disclosure Statement
`
`Mail Stop Amendment
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Listed on the accompanying form equivalent to form PTO/SB/08b are documents that may
`
`be considered material to the patentability of this application as defined in 37 C.F.R. §1.56. This
`
`IDS is being filed in compliance with the duty of disclosure requirements of 37 C.F.R. §§ 1.97 and
`
`1.98. The numbering on this First Supplemental Information Disclosure Statement is a continuation
`
`of the numbering in Applicant's Information Disclosure Statement filed on September 19, 2017, in
`
`connection with the above-captioned application.
`
`Applicant has listed the publication date on the attached form based on information
`
`presently available to the undersigned. However, the listed publication date should not be construed
`
`as an admission that the information was actually published on the date indicated.
`
`Applicant reserves the right to establish the patentability of the claimed invention over any
`
`of the information provided herewith, and/or to prove that this information may not be prior art,
`
`and/or to prove that this information may not be enabling for the teachings purportedly offered.
`
`This statement should not be construed as a representation that a search has been made, or
`
`that information more material to the examination of the present patent application does not exist.
`
`The Examiner is specifically requested not to rely solely on the material submitted herewith.
`
`
`
`- 2 -
`
`OKSCHE el al.
`
`Application No. 15/442,231
`
`This is being filed under 37 C.F.R. § 1.97(b). This Information Disclosure Statement is
`
`being filed before the mailing of a first Office Action after the filing of a request for continued
`
`examination under 37 C.F.R. § 1.114. No statement or fee is required.
`
`A copy of document NPL97-NPL99 are submitted.
`
`It is respectfully requested that the Examiner initial and return a copy of the enclosed IDS
`
`Form, and indicate in the official file wrapper of this patent application that the documents have
`
`been considered.
`
`The US. Patent and Trademark Office is hereby authorized to charge any fee deficiency, or
`
`credit any overpayment, to our Deposit Account No. 19-0036.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Matthew S. Bodenstein/
`
`Matthew S. Bodenstein
`
`Attorney for Applicant
`Registration No. 58,885
`
`Date:
`
`August 10, 2018
`
`1100 New York Avenue, NW.
`Washington, DC. 20005-3934
`(202) 371-2600
`
`9169188_l
`
`Atty. Dkt. No. 1861.2700005/JMC/MSB
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
